Ribavirin: beginning the blitz on respiratory viruses?
D000328:Adult; D000336:Aerosols; D000818:Animals; D006801:Humans; D007223:Infant; D007251:Influenza, Human / Q000188:drug therapy; D018184:Paramyxoviridae Infections / Q000188:drug therapy; D012136:Respiratory Syncytial Viruses / Q000187:drug effects; D012141:Respiratory Tract Infections / Q000188:drug therapy*; D010253:Respirovirus Infections / Q000188:drug therapy; D012254:Ribavirin / Q000008:administration & dosage / Q000009:adverse effects / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use*; D012263:Ribonucleosides / Q000627:therapeutic use*; D014777:Virus Diseases / Q000188:drug therapy*; D014780:Viruses / Q000187:drug effects
D000336:Aerosols; D012263:Ribonucleosides; D012254:Ribavirin